United States · FDA National Drug Code directory
Actos
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-151_20e43dff-4bf2-4ae7-82a1-e7e895123f93
- Product NDC
- 64764-151
- Form
- TABLET
- Composition / generic term
- pioglitazone
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19990715
- Source listing expiry
- 20261231
Source-listed ingredients
- PIOGLITAZONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CARTON in 1 TRAY (64764-151-02) / 1 BLISTER PACK in 1 CARTON / 7 TABLET in 1 BLISTER PACK · 64764-151-02
- 30 TABLET in 1 BOTTLE (64764-151-04) · 64764-151-04
- 90 TABLET in 1 BOTTLE (64764-151-05) · 64764-151-05
- 500 TABLET in 1 BOTTLE (64764-151-06) · 64764-151-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →